What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Obesity
- Weight loss
His primary areas of investigation include Weight loss, Obesity, Physical therapy, Randomized controlled trial and Overweight.
Weight loss is a subfield of Internal medicine that Thomas A. Wadden investigates.
His study in Obesity is interdisciplinary in nature, drawing from both Surgery, Pediatrics and MEDLINE.
His research integrates issues of Weight control, Pharmacotherapy and Disease management in his study of Physical therapy.
His research on Randomized controlled trial also deals with topics like
- Sibutramine, which have a strong connection to Clinical trial,
- Very low calorie diet together with Combined treatment.
His study in the fields of Childhood obesity under the domain of Overweight overlaps with other disciplines such as Task force.
His most cited work include:
- 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society (2212 citations)
- 2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk (1605 citations)
- Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. (1600 citations)
What are the main themes of his work throughout his whole career to date?
Thomas A. Wadden mainly focuses on Weight loss, Obesity, Internal medicine, Physical therapy and Randomized controlled trial.
His biological study spans a wide range of topics, including Diabetes mellitus, Type 2 diabetes, Placebo and Surgery.
Thomas A. Wadden combines subjects such as Body mass index, Gerontology and Clinical psychology with his study of Obesity.
His research in Internal medicine intersects with topics in Liraglutide and Endocrinology, Depression.
His Physical therapy study incorporates themes from MEDLINE, Intervention, Quality of life, Primary care and Weight control.
The study incorporates disciplines such as Psychological intervention, Pharmacotherapy, Clinical trial and Sibutramine in addition to Randomized controlled trial.
He most often published in these fields:
- Weight loss (62.02%)
- Obesity (58.21%)
- Internal medicine (28.63%)
What were the highlights of his more recent work (between 2017-2021)?
- Obesity (58.21%)
- Weight loss (62.02%)
- Randomized controlled trial (25.95%)
In recent papers he was focusing on the following fields of study:
Thomas A. Wadden spends much of his time researching Obesity, Weight loss, Randomized controlled trial, Internal medicine and Overweight.
His Obesity study combines topics in areas such as Body mass index, Cognition, Randomization and Clinical psychology.
The various areas that Thomas A. Wadden examines in his Weight loss study include Liraglutide, Placebo, Pharmacotherapy and Physical therapy.
His Randomized controlled trial research focuses on Weight change and how it connects with Weight gain.
His studies in Internal medicine integrate themes in fields like Depression and Mood.
His Overweight research is multidisciplinary, incorporating perspectives in Observational study, Semaglutide, Gerontology, Beck Depression Inventory and Type 2 diabetes.
Between 2017 and 2021, his most popular works were:
- The Science of Obesity Management: An Endocrine Society Scientific Statement. (194 citations)
- Psychopathology, disordered eating, and impulsivity as predictors of outcomes of bariatric surgery (38 citations)
- Group cognitive-behavioral treatment for internalized weight stigma: a pilot study (31 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Obesity
- Disease
The scientist’s investigation covers issues in Obesity, Weight loss, Randomized controlled trial, Weight management and Internal medicine.
His Obesity research is multidisciplinary, incorporating elements of Psychiatry, Cognition, Intensive care medicine, Disease and Clinical psychology.
His Weight loss research integrates issues from Body mass index, Overweight, Targeted interventions, Food craving and Quality of life.
The Overweight study combines topics in areas such as Type 2 diabetes, Gerontology and Semaglutide.
His Randomized controlled trial research incorporates themes from Behavioral therapy, Medicaid, Placebo, Pharmacotherapy and Physical therapy.
His work in Internal medicine covers topics such as Liraglutide which are related to areas like Odds ratio and Meal.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
